Cadonilimab (Anti-PD-1 & CTLA-4)
Product Specifications
CAS Number
2394841-59-7
Synonyms
AK104
Target
PD-1/PD-L1
Applications
Apoptosis
Additionnal Information
Cadonilimab is a humanized tetravalent bispecific IgG1 antibody targeting human PD-1 and CTLA-4 with potential immune checkpoint inhibitory and antineoplastic activities. It has the potential to treat recurrent or metastatic cervical cancer. MW : 198.64 KD.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680177-500 1x 500 µL
CD50 (ICAM-3) (101-1D2), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400181-100 1x 100 µL
CD59 (heavy chain of Protectin) (BRA-10G), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680270-100 1x 100 µL
Fibronectin (HFN7.1), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680977-100 1x 100 µL
TGF-beta (1D11.16.8), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details